Evidence map›Paper›PMID 35989271›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.

Yuki Chiko, Yuka Sugisaki, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Akihiko Taniguchi, Eiki Ichihara, Toshiaki Okada

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuki ChikoDepartment of Internal Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Yuka SugisakiDepartment of Internal Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Keiji MiyoshiDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Daisuke MorichikaDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Yuka BeikaDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Akihiko TaniguchiDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
Eiki IchiharaDepartment of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.
Toshiaki OkadaDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan.
National Hospital Organization · JPOkayama University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 72-year-old woman with opsoclonus visited our hospital and was diagnosed with small-cell lung cancer. Blood tests revealed anti-SOX1 antibodies, so the patient was diagnosed with paraneoplastic opsoclonus-myoclonus syndrome. After steroid pulse therapy was started, chemotherapy of treatment, the opsoclonus showed an improving trend. Anti-Ri and anti-Hu antibodies have been reported as autoantibodies associated with neoplastic opsoclonus-myoclonus syndrome; however, there are no such reports concerning anti-SOX1 antibody. Therefore, this is a valuable case.

Indexed as

Lung NeoplasmsOcular Motility DisordersOpsoclonus-Myoclonus SyndromeSmall Cell Lung CarcinomaAgedAutoantibodiesFemaleHumansAutoantibodiesanti-SOX1 antibodyopsoclonusparaneoplastic neurological syndromesmall-cell lung cancer

Identifiers

PMID35989271
PMCPMC10076147
OpenAlexW4293069239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.